The safety of Ipsilateral high-frequency repetitive Transcranial Magnetic Stimulation in brain tumour patients - Poll - MDSpire

The safety of Ipsilateral high-frequency repetitive Transcranial Magnetic Stimulation in brain tumour patients

  • By

  • Ali, Ahmad M. S.

  • Asman, Priscella

  • Chilakapati, Sai S.

  • Jenkinson, Michael D.

  • Zakaria, Rasheed

  • Prabhu, Sujit

  • May 7, 2026

  • 0 min

Share

Original Source(s)

The safety of Ipsilateral high-frequency repetitive Transcranial Magnetic Stimulation in brain tumour patients

  • by Ali, Ahmad M. S., Asman, Priscella , Chilakapati, Sai S., Jenkinson, Michael D., Zakaria, Rasheed , Prabhu, Sujit

  • May 7, 2026

Related Content

Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement

Clinical GBM hybrid artificial intelligence for prescription dose recommendation and outcome prediction after gamma knife radiosurgery treatment: a proof-of-concept

Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors?